Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study

BACKGROUND: From 2012 through 2014, the United States experienced acute shortages and price escalations of several first-line anti-tuberculosis (TB) medications. Because secondary TB drug regimens are longer and adverse events occur more frequently with them, we sought to conservatively estimate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, James C., Shah, Neha, Porco, Travis, Flood, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540488/
https://www.ncbi.nlm.nih.gov/pubmed/26284924
http://dx.doi.org/10.1371/journal.pone.0134597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540488/
https://www.ncbi.nlm.nih.gov/pubmed/26284924
http://dx.doi.org/10.1371/journal.pone.0134597

Ejemplares similares